-
Clinical Observation of Hydrogen-Rich Saline for Nasal Irrigation After Surgery for Chronic sinusitis:A Randomized, Double-Blind, Controlled Trial
15 Oct 2024 08:44 GMT
… of clinical CRS treatment research.
Medical research around hydrogen … double-blind controlled clinical trial. Recruitment and follow … of patients and observation doctors. The experimental group … . The effectiveness of budesonide nasal irrigation after endoscopic …
-
Race-Based Pulmonary Function Testing Correction in COPD Inhaler Therapy Trials: A Systematic Review
12 Oct 2024 09:01 GMT
… underrepresented in clinical trials in pulmonary medicine, with current COPD treatments predominantly evaluated … to be included within the trial. This may contribute to the … , et al. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate …
-
Potential Drug Targets and Pathways in the Pathogenesis of Psoriasis
10 Oct 2024 15:14 GMT
… Analysis (WGCNA), GWAS Analysis, and Drug Target Prediction.
The results showed … for further analysis. The Drug Target Prediction analysis indicated that … profiles influenced by specific medications, such as methotrexate, budesonide, amino purvalanol-A …
-
Posters Reveal Early COPD Treatment Benefits, Highlight Superior Adherence With Single-Inhaler Triple Therapy
10 Oct 2024 08:56 GMT
… of the appropriate initial pharmacological treatment (IPT) is needed, with … an appropriate treatment," Presenter Kristi DiRocco, PharmD, respiratory medical director at … /UMEC/VI or budesonide/glycopyrronium/formoterol fumarate …
-
AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint
08 Oct 2024 09:55 GMT
… pharmaceutical company AstraZeneca has reported that its Phase IIIb BATURA trial … of Airsupra (albuterol/budesonide) in … budesonide – 180 micrograms (mcg)/160mcg – as an as-needed rescue medication … for as-needed treatment or prevention of …
-
BATURA Trial Shows Airsupra Reduces Severe Asthma Exacerbation Risk in Patients with Mild, Intermittent Asthma
07 Oct 2024 19:56 GMT
Treatment with Airsupra (albuterol/budesonide; AstraZeneca, Avillion) as a rescue medication was found … .
Airsupra was approved by the FDA last year based on findings … trials. The MANDALA trial showed that Airsupra as an as-needed rescue medication …
-
Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma
07 Oct 2024 22:40 GMT
… phase 3 MANDALA and DENALI trials, the FDA in January 2023 approved … trial compared the efficacy and safety of using inhaled albuterol/budesonide … -inflammatory rescued medication approved by the US FDA for as needed treatment or …
-
AstraZeneca/Avillion share positive phase 3 results for asthma rescue treatment Airsupra
08 Oct 2024 07:33 GMT
… and older.
Airsupra (albuterol/budesonide) demonstrated a statistically significant and … monitoring committee recommended that the trial should end early due to … medication to be approved in the US for the as-needed treatment …
-
AstraZeneca's BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint
08 Oct 2024 04:08 GMT
… phase IIIb trial showed AstraZeneca’s Airsupra (albuterol/budesonide) met the … rescue medication approved in the US for the as-needed treatment or … MANDALA and DENALI phase III trials. Airsupra is also being studied …
-
AstraZeneca heads to regulators after Airsupra asthma trial stops early thanks to 'overwhelming efficacy'
07 Oct 2024 20:14 GMT
… trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide … an as-needed rescue medication versus albuterol alone, AZ … therapy.
The drug-device combo’s original FDA approval in early … first-in-class rescue treatment and its role in …